内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Richo Anna, 董事. Insider active across 3 companies, notably Adamas Pharmaceuticals Inc. Aggregated, 15 reports have been recorded. Activity tracked since 2 June 2021. The latest transaction was filed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Richo Anna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
878 股@ US$49.8212.9% 占其流量Common stock- deferred stock unitsSEC:0001199306-26-000004:0
940 股@ US$43.878.8% 占其流量Common stock- deferred stock unitsSEC:0001199306-26-000002:0
950 股@ US$43.439.7% 占其流量Common stock- deferred stock unitsSEC:0001199306-25-000005:0
954 股@ US$43.2510.7% 占其流量Common stock- deferred stock unitsSEC:0001109357-25-000154:0
3,780 股0Common StockSEC:0001127602-25-015506:0
933 股@ US$44.1915.0% 占其流量Common stock- deferred stock unitsSEC:0001109357-25-000090:0
1,119 股@ US$36.8715.6% 占其流量Common stock- deferred stock unitsSEC:0001109357-25-000010:0
1,025 股@ US$40.2314.5% 占其流量Common stock- deferred stock unitsSEC:0001109357-24-000168:0
1,161 股@ US$35.5415.1% 占其流量Common stock- deferred stock unitsSEC:0001109357-24-000142:0
2,622 股0Common StockSEC:0001127602-24-016276:0
1,131 股@ US$36.4815.0% 占其流量Common stock- deferred stock unitsSEC:0001109357-24-000090:0
1,052 股@ US$39.2114.6% 占其流量Common stock- deferred stock unitsSEC:0001109357-24-000014:0
674 股@ US$40.5810.2% 占其流量Common stock- deferred stock unitsSEC:0001109357-23-000081:0
25,000 股Common StockSEC:0001328143-21-000088:0
5,000 股0Common StockSEC:0001328143-21-000061:0
About Richo Anna
RICHO ANNA is an Administrateur who has filed 15 filings in total. Across the 15 recent filings observed, they relate to EXELON CORP, Illumina, INC. and Adamas Pharmaceuticals Inc, with transaction nature mainly Attributions, and the buy and sell amounts shown are both EUR 0. The period covered by these filings runs from 2021-06-04 to 2026-04-01.